Complete Response Resubmission Accepted - PDUFA Date September 29, 2018
The Company Anticipates Second Quarter 2018 Resubmission
Record Annual Revenue of $54.5 Million
Investors in Antares Pharma Inc. saw new options become available this week, for the April 20th expiration.
AMAG Pharmaceuticals Makena® Subcutaneous Auto-Injector Approved To Reduce The Risk Of Preterm Birth In Certain At-Risk Women
AMAG Pharmaceuticals Makena® Subcutaneous Auto-Injector Approved To Reduce The Risk Of Preterm Birth In Certain At-Risk Women
Glancy Prongay & Murray LLP ("GPM") reminds investors of the December 22, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Antares Pharma, Inc.
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Antares Pharma, Inc.
Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, reminds investors that a class action lawsuit has been filed against Antares Pharma, Inc.
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Antares Pharma, Inc.
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Antares Pharma, Inc.
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Antares Pharma, Inc.
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Antares Pharma, Inc.
We'd rather get ahead of that coming wave of year-end tax loss selling.
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Antares Pharma, Inc.
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Antares Pharma, Inc.
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Antares Pharma, Inc.
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...
Record Quarterly Revenue of $15.1 Million and Net Loss Per Share of $0.03
